Kinase insert domain receptor

From Food & Medicine Encyclopedia

Kinase insert domain receptor (KDR), also known as vascular endothelial growth factor receptor 2 (VEGFR-2), is a vascular endothelial growth factor (VEGF) receptor. KDR is a type of receptor tyrosine kinase (RTK) that is predominantly expressed in endothelial cells and plays a crucial role in angiogenesis and vasculogenesis.

Structure[edit]

The KDR protein is a transmembrane receptor composed of seven immunoglobulin-like domains in the extracellular domain, a single transmembrane spanning region, and a cytoplasmic tyrosine kinase domain split by a kinase-insert domain. The kinase insert domain is unique to KDR and other related receptors, hence the name "kinase insert domain receptor".

Function[edit]

KDR is a key mediator of VEGF-induced endothelial proliferation, survival, and migration and tubulogenesis. It is also a cellular receptor for macrophage-stimulating protein (MSP) which upon binding induces its dimerization and autophosphorylation.

Clinical significance[edit]

Mutations in KDR gene are associated with infantile capillary hemangiomas. In addition, KDR/VEGFR-2 is a major target for anti-angiogenic drug therapy in cancer treatment.

See also[edit]

References[edit]

<references />


Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.